Plain-English translation of NCT06910761 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing photon craniospinal irradiation (a type of radiation therapy that targets the entire brain and spinal cord) in patients with advanced breast cancer or non-small cell lung cancer that has spread to the leptomeninges — the protective layers of tissue surrounding the brain and spinal cord. Researchers want to see if this treatment can stop or slow this type of cancer spread, improve how long patients survive, and understand how it affects quality of life.
When breast or lung cancer spreads to the membranes around the brain and spinal cord, it is very difficult to treat and patients typically have few options. This trial exists to see if a more comprehensive radiation approach can help patients with this serious condition live longer and maintain their quality of life.
You likely qualify if…
You likely don't qualify if…
You will receive radiation therapy once a day, Monday through Friday, for 10 total treatments over 2–3 weeks. During the trial, you will have brain and spinal cord imaging (MRI scans), blood tests, and samples of spinal fluid taken before, during, and after treatment. You will also complete questionnaires about your quality of life, anxiety, and thinking and memory. After treatment ends, you will have follow-up visits at 1 month and then every 3 months for up to 1 year to monitor how you are doing.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
United States